GOLDBERG MICHAEL M

CIK 00009050116 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0000905011

Recent Transactions

31 trades

Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock, $.001 par value
2017-05-16$0.46/sh+106,021→ 5,921,023 total
Award
Echo Therapeutics, Inc.
Comon Stock, par value $.01
2017-03-21+25,000→ 39,500 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB Common Stock, $.001 par value
2017-01-17$0.01/sh+5,411,850→ 5,815,002 total
Exercise of In-Money
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrants (Right to Buy)
2017-01-17−5,411,850→ 0 total
Other
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrants (Right to Buy)
2016-10-17$2.07/sh+5,411,850→ 5,411,850 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2016-07-06$0.50/sh+43,580→ 403,152 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2016-04-20+28,000→ 359,572 total
Award
Echo Therapeutics, Inc.
Options (Right to Buy)
2016-03-21+150,000→ 18,750 total
Award
Echo Therapeutics, Inc.
Options (Right to Buy)
2016-03-01+150,000→ 37,500 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2015-10-08$2.26/sh+13,247→ 331,572 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2015-03-26+22,000→ 318,325 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2015-02-05$1.89/sh+6,614→ 296,325 total
Award
Echo Therapeutics, Inc.
Stock Option
2015-01-07$1.62/sh+150,000→ 150,000 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2014-11-14$1.12/sh+28,359→ 289,711 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2014-11-13$1.06/sh+71,641→ 261,352 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2014-11-10$1.32/sh+9,470→ 189,711 total
Award
Echo Therapeutics, Inc.
Nonqualified Stock Option (right to buy)
2014-02-28+56,000→ 56,000 total
Award
Echo Therapeutics, Inc.
Comon Stock
2014-02-28+14,500→ 14,500 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2014-02-13+20,000→ 180,241 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2013-11-18+12,250→ 160,241 total
Award
Adynxx, Inc.
Stock Option (right to buy)
2012-05-14+75,000→ 1,325,000 total
Purchase
Adynxx, Inc.
Common Stock Warrants (right to buy)
2012-02-16+1,000,000→ 3,250,000 total
Purchase
Adynxx, Inc.
Common Stock
2012-02-16+2,000,000→ 2,250,000 total
Award
Adynxx, Inc.
Stock Option (right to buy)
2011-01-03+250,000→ 250,000 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2010-06-30+4,000→ 4,000 total
Award
Savara Inc$SVRA
Non-qualified Stock Option (Right to Buy)
2010-02-02+100,000→ 100,000 total
Award
Savara Inc$SVRA
Non-qualified Stock Option (Right to Buy)
2010-02-02+100,000→ 100,000 total
Other
Vaneltix Pharma, Inc.
Convertible Note
2009-08-13$0.10/sh+202,500→ 2,025,500 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2007-05-23+50,000→ 50,000 total
Disposition to Issuer
EMISPHERE TECHNOLOGIES INC
Common Stock
2005-08-08$3.56/sh−46,132→ 132,410 total
Award
EMISPHERE TECHNOLOGIES INC
Stock Option (right to buy)
2005-04-28+200,000→ 200,000 total

Companies

Recent Filings

Address

C/O MONTAUR CAPITAL PARTNERS 152 WEST 57TH STREET, 4TH FLOOR

NEW YORK, NY, 10019

View on SEC.gov